Melanie T Benson Marshall, Stephen Pinfield, Pamela Abbott, Andrew Cox, Juan Pablo Alperin, Natascha Chtena, Alice Fleerackers
{"title":"\"It's messy and it's massive\": How has the open science debate developed in the post-COVID era?","authors":"Melanie T Benson Marshall, Stephen Pinfield, Pamela Abbott, Andrew Cox, Juan Pablo Alperin, Natascha Chtena, Alice Fleerackers","doi":"10.12688/f1000research.162577.1","DOIUrl":null,"url":null,"abstract":"<p><p>The COVID-19 pandemic accelerated the global adoption of open science (OS) practices. However, as the pandemic subsides, the debate around OS continues to evolve. This study investigates how the pandemic has shaped the OS discourse and identifies key issues and challenges. Interviews were conducted with influential stakeholders across the research and publishing communities. The findings show that while many areas of debate remained constant, the ways in which they were discussed exposed underlying systemic challenges, which must be addressed if OS is to progress. These issues included the scope and definition of OS; regional variations in its implementation; the relationship between OS and fundamental questions of the purpose and practice of science; and the need to reform incentives and reward structures within the research system. A more complex understanding of OS is required, which takes into account the importance of equity and diversity and the challenges of implementing OS in different cultural and geographical contexts. The study emphasises the importance of shifting scientific culture to prioritise values such as quality, integrity, and openness, and reforming rewards structures to incentivise open practices.</p>","PeriodicalId":12260,"journal":{"name":"F1000Research","volume":"14 ","pages":"500"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171716/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"F1000Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12688/f1000research.162577.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
The COVID-19 pandemic accelerated the global adoption of open science (OS) practices. However, as the pandemic subsides, the debate around OS continues to evolve. This study investigates how the pandemic has shaped the OS discourse and identifies key issues and challenges. Interviews were conducted with influential stakeholders across the research and publishing communities. The findings show that while many areas of debate remained constant, the ways in which they were discussed exposed underlying systemic challenges, which must be addressed if OS is to progress. These issues included the scope and definition of OS; regional variations in its implementation; the relationship between OS and fundamental questions of the purpose and practice of science; and the need to reform incentives and reward structures within the research system. A more complex understanding of OS is required, which takes into account the importance of equity and diversity and the challenges of implementing OS in different cultural and geographical contexts. The study emphasises the importance of shifting scientific culture to prioritise values such as quality, integrity, and openness, and reforming rewards structures to incentivise open practices.
F1000ResearchPharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
5.00
自引率
0.00%
发文量
1646
审稿时长
1 weeks
期刊介绍:
F1000Research publishes articles and other research outputs reporting basic scientific, scholarly, translational and clinical research across the physical and life sciences, engineering, medicine, social sciences and humanities. F1000Research is a scholarly publication platform set up for the scientific, scholarly and medical research community; each article has at least one author who is a qualified researcher, scholar or clinician actively working in their speciality and who has made a key contribution to the article. Articles must be original (not duplications). All research is suitable irrespective of the perceived level of interest or novelty; we welcome confirmatory and negative results, as well as null studies. F1000Research publishes different type of research, including clinical trials, systematic reviews, software tools, method articles, and many others. Reviews and Opinion articles providing a balanced and comprehensive overview of the latest discoveries in a particular field, or presenting a personal perspective on recent developments, are also welcome. See the full list of article types we accept for more information.